You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Agilent, which sees metabolomics as a "major growth area," will provide a 1290 Infinity HPLC, a mass spec, and software to Stemina.
Thermo Fisher will team with a new proteomics research group that is part of CRP-Santé to develop workflows for biomarker discovery and assay development for clinical proteomics research.
Telegraph Hill Partners led a financing round that will support AltheaDx's companion diagnostic partnerships.
The venture will use MMI's myostatin tools in technologies to increase productivity and disease resistance in fish.
The Kluyver Centre in the Netherlands and Genedata have extended a collaboration for the Expressionist and Phylosopher systems.
A Johns Hopkins University and Life Technologies team reports that they have developed a whole-genome sequencing method called personalized analysis of rearranged ends, or PARE, for finding patient-specific cancer biomarkers.
Parexel will offer the PS Biomarker Services to biopharma firms seeking biomarkers to assess new compounds.
The company has completed paying off a $600,000 settlement agreement for using Health Discovery Corporation's SVM IP for protein biomarker discovery.
The papers by members of NCI's proteomics group and NIST provide new tools and solutions for the proteomics community in the quest to upgrade the quality of their research.
The pharmaceutical firm will have access to GeneNews' genomic biomarker program.
Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.
Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.
The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.
This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.